| 摘要 |
<p>The invention relates to medicine and to the pharmaceutical industry and concerns the composition of a preparation of a highly effective pharmaceutical substance and auxiliary substances which enable the formation of a fine-particle aerosol for the purpose of penetrating into the bronchi and alveoli of the lungs. An inhalable composition in the form of an aerosol for treating diseases of the respiratory organs contains salmeterol or salmeterol xinafoate, fluticasone or fluticasone propionate, a propellant modifier in the form of perfluorodecalin, and a propellant, selected from 1,1,1,4 tetrafluoroethane (HFA-134a) and/or 1,1,1,2,3,3,3-heptafluoropropane (HFA-227ea).</p> |
